Jaguar Health Inc (NASDAQ: JAGX) Is Worth Evaluating At $2.78

During the last session, Jaguar Health Inc (NASDAQ:JAGX)’s traded shares were 0.2 million, with the beta value of the company hitting 0.70. At the end of the trading day, the stock’s price was $2.78, reflecting an intraday loss of -14.06% or -$0.45. The 52-week high for the JAGX share is $110.75, that puts it down -3883.81 from that peak though still a striking -11.15% loss since the share price plummeted to a 52-week low of $3.09. The company’s market capitalization is $3.51M, and the average trade volume was 139.97K shares over the past three months.

Jaguar Health Inc (JAGX) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. JAGX has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it.

Jaguar Health Inc (NASDAQ:JAGX) trade information

Jaguar Health Inc (JAGX) registered a -14.06% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -14.06% in intraday trading to $2.78, hitting a weekly high. The stock’s 5-day price performance is -27.03%, and it has moved by -51.74% in 30 days. Based on these gigs, the overall price performance for the year is -97.25%.

The consensus price target of analysts on Wall Street is $12.98, which implies an increase of 78.58% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $12.98 and $12.98 respectively. As a result, JAGX is trading at a discount of -366.91% off the target high and -366.91% off the low.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 86.61%. While earnings are projected to return 84.85% in 2025, the next five years will return 83.11% per annum.

JAGX Dividends

Jaguar Health Inc is due to release its next quarterly earnings on 2025-May-15. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.